发明名称 |
CDK9 inhibitors in the treatment of midline carcinoma |
摘要 |
<p>The present invention relates to a CDK9 inhibitor, especially a selective CDK9 inhibitor, for use in treating, ameliorating and/or preventing midline carcinoma. Also corresponding methods for treating, preventing or ameliorating midline carcinoma are subject of the present invention. Preferably, NUT midline carcinoma is treated with the CDK9 inhibitors in accordance with the present invention.</p> |
申请公布号 |
AU2012298483(A1) |
申请公布日期 |
2014.03.06 |
申请号 |
AU20120298483 |
申请日期 |
2012.08.22 |
申请人 |
MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V.;LEAD DISCOVERY CENTER GMBH |
发明人 |
CHOIDAS, AXEL;KLEBL, BERT;HABENBERGER, PETER;EICKHOFF, JAN;THOMAS, ROMAN;HEUCKMANN, JOHANNES |
分类号 |
A61K31/00;A61K31/4418;A61K31/53;A61P35/00 |
主分类号 |
A61K31/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|